Wessel’s research involves the development and optimisation of process routes antitubercular drugs with a focus on method development and scale-up strategies. Research highlights include the development of semi-flow approaches to the synthesis of a basket of pharmaceuticals used for the tuberculosis including isoniazid, pyrazinamide and ethambutol.